PDE6D

phosphodiesterase 6D, the group of Phosphodiesterases

Basic information

Region (hg38): 2:231732433-231786272

Links

ENSG00000156973NCBI:5147OMIM:602676HGNC:8788Uniprot:O43924AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Joubert syndrome 22 (Moderate), mode of inheritance: AR
  • Joubert syndrome 22 (Strong), mode of inheritance: AR
  • orofaciodigital syndrome type 6 (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Joubert syndrome 22ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic; Ophthalmologic; Renal24166846

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PDE6D gene.

  • Joubert syndrome 22 (4 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE6D gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
18
clinvar
18
missense
18
clinvar
2
clinvar
20
nonsense
1
clinvar
1
start loss
0
frameshift
3
clinvar
1
clinvar
4
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
4
6
non coding
9
clinvar
9
Total 4 1 18 29 0

Highest pathogenic variant AF is 0.00000657

Variants in PDE6D

This is a list of pathogenic ClinVar variants found in the PDE6D region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-231732981-T-C Joubert syndrome 22 Uncertain significance (Jul 05, 2022)2159721
2-231732996-C-T Joubert syndrome 22 Likely benign (Feb 03, 2025)541700
2-231732997-G-A Joubert syndrome 22 Likely benign (Dec 13, 2023)771080
2-231732999-C-T PDE6D-related disorder • Joubert syndrome 22 Likely benign (Jan 20, 2025)772599
2-231733000-G-A Joubert syndrome 22 Likely benign (Oct 03, 2023)1577483
2-231733003-A-G Likely benign (Jul 20, 2018)764748
2-231733015-T-A Joubert syndrome 22 Uncertain significance (Apr 13, 2021)1525951
2-231733040-G-T Joubert syndrome 22 Likely benign (Nov 15, 2022)1523392
2-231737174-C-A Joubert syndrome 22 Likely benign (Jan 25, 2025)3679206
2-231737179-T-G Joubert syndrome 22 Benign/Likely benign (Jan 20, 2025)446086
2-231737190-A-AC Joubert syndrome 22 Pathogenic/Likely pathogenic (Dec 29, 2020)590801
2-231737194-C-T Joubert syndrome 22 Uncertain significance (Aug 01, 2022)1360750
2-231737195-G-A Joubert syndrome 22 Likely benign (Dec 03, 2021)1625889
2-231737199-G-T Joubert syndrome 22 Uncertain significance (Aug 26, 2021)1371082
2-231737209-T-C Inborn genetic diseases Uncertain significance (Jun 28, 2023)2606958
2-231737213-G-A Joubert syndrome 22 Likely benign (Dec 10, 2023)2702103
2-231737215-AC-A Joubert syndrome 22 Pathogenic (Jun 01, 2022)2001656
2-231737225-T-C Likely benign (Jun 01, 2018)748209
2-231737230-C-T Joubert syndrome 22 Uncertain significance (Sep 06, 2022)1392287
2-231737247-G-A Joubert syndrome 22 Uncertain significance (Oct 13, 2020)999226
2-231737254-T-G Joubert syndrome 22 Uncertain significance (Feb 24, 2022)1508371
2-231737260-T-C Joubert syndrome 22 Uncertain significance (Jul 04, 2022)2026306
2-231737295-G-A Joubert syndrome 22 Uncertain significance (Jul 26, 2022)1354430
2-231738020-G-A Joubert syndrome 22 Likely benign (Dec 17, 2024)772606
2-231738020-GC-G Joubert syndrome 22 Likely pathogenic (Apr 05, 2022)917951

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PDE6Dprotein_codingprotein_codingENST00000287600 553848
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.006420.9191257380101257480.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.604587.00.5170.00000490991
Missense in Polyphen929.7340.30269356
Synonymous0.1573031.10.9640.00000195275
Loss of Function1.54510.30.4845.99e-7101

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009060.0000905
Ashkenazi Jewish0.00009950.0000992
East Asian0.00005480.0000544
Finnish0.000.00
European (Non-Finnish)0.00004420.0000439
Middle Eastern0.00005480.0000544
South Asian0.00003280.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Promotes the release of prenylated target proteins from cellular membranes (PubMed:9712853). Modulates the activity of prenylated or palmitoylated Ras family members by regulating their subcellular location (PubMed:22002721, PubMed:23698361). Required for normal ciliary targeting of farnesylated target proteins, such as INPP5E (PubMed:24166846). Modulates the subcellular location of target proteins by acting as a GTP specific dissociation inhibitor (GDI) (By similarity). Increases the affinity of ARL3 for GTP by several orders of magnitude. Stabilizes ARL3-GTP by decreasing the nucleotide dissociation rate (By similarity). {ECO:0000250|UniProtKB:O55057, ECO:0000269|PubMed:10518933, ECO:0000269|PubMed:22002721, ECO:0000269|PubMed:23559067, ECO:0000269|PubMed:23698361, ECO:0000269|PubMed:24166846, ECO:0000269|PubMed:9712853}.;
Pathway
Purine metabolism - Homo sapiens (human);Phosphodiesterases in neuronal function;Purine nucleotides nucleosides metabolism;ARL13B-mediated ciliary trafficking of INPP5E;Cargo trafficking to the periciliary membrane;Cilium Assembly;Organelle biogenesis and maintenance (Consensus)

Recessive Scores

pRec
0.191

Intolerance Scores

loftool
0.500
rvis_EVS
0.48
rvis_percentile_EVS
78.95

Haploinsufficiency Scores

pHI
0.392
hipred
Y
hipred_score
0.705
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.995

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pde6d
Phenotype
normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
pde6d
Affected structure
pronephric tubule
Phenotype tag
abnormal
Phenotype quality
distended

Gene ontology

Biological process
visual perception;negative regulation of GTPase activity;response to stimulus
Cellular component
cytosol;cytoskeleton;cilium;cytoplasmic vesicle membrane;cytoplasmic vesicle
Molecular function
3',5'-cyclic-nucleotide phosphodiesterase activity;GTPase inhibitor activity;protein binding;Rab GTPase binding